Skip to main content
. 2021 Apr 2;128(7):1040–1061. doi: 10.1161/CIRCRESAHA.121.318051

Figure 4.

Figure 4.

Algorithm for the screening, monitoring, and treatment of blood pressure in patients with cancer receiving antineoplastic therapy known to be associated with hypertension. ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BB, β-blocker; BP, blood pressure; CCB, dihydropyridine calcium channel blocker; CKD, chronic kidney disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; IHD, ischemic heart disease; MRA, mineralocorticoid receptor antagonist; PVD, peripheral vascular disease; and SBP, systolic blood pressure.